Advertisement

Topics

Cancer Corporate

14:43 EDT 26th May 2017 | BioPortfolio

Sigmascreening

Sigmascreening, founded in 2009, is an Amsterdam based MedTech company focusing on the development of new innovative products in the area of digital mammography and breast cancer

ORYX GmbH & Co. KG

ORYX is a privately held Munich-based biotech company. ORYX is developing three highly innovative drug candidates for the treatment of cancer, originating from leading research institutions like the German Cancer Research Center (DKFZ) and the University of Heidelberg. The ORYX clinical development portfolio consists of an oncolytic virus and two therapeut...

NovellusDx

A precision oncology company that developed a novel live cell based assay to characterize the activity of unknown cancer mutations and test their response to targeted therapies. NovellusDx helps biopharma throughout the drug life cycle, from target discovery through clinical development to market expansion. More information: www.novellusdx.com.

Canines-N-Kids Foundation

WHATCanines-N-Kids Foundation, a nonprofit committed to finding a cure to the devastating cancers that canines and children both develop, is hosting the first Paws for a Cure Summit. With a significant grant from the Petco Foundation in conjunction with the Blue Buffalo Foundation, the event is convening the foremost leaders and researchers i...

SIWA Therapeutics

SIWA Therapeutics is a privately held biotechnology company based in Chicago. SIWA has shown that its monoclonal antibody, SIWA 318, targets and destroys senescent cells in animal models without observable side effects of treatment. Although senescent cells are causally implicated in a wide variety of diseases including neurodegenerative diseases, autoimmu...

Novelogics Biotechnology, Inc. and The Centre for Drug Research and Development (CDRD)

Novelogics Biotechnology Inc. is virtual life sciences company utilizing expertise at a variety of Contract Research labs and is dedicated to developing innovative cancer treatments that harness the power of the immune system to help eradicate tumors more naturally. Their immunotherapy concepts focus on development of antibody therapeutics and have the pot...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology investigates biomarkers at the structural level as opposed to overall concentration, giving better insights as to its cellular origin. Its pipeline of high performance, non-invasive ca...

Gift of Life Marrow Registry

The Gift of Life Marrow Registry is a national non-profit headquartered in Boca Raton, Fla. The organization, established in 1991, is dedicated to curing blood cancer through marrow and stem cell donation. To learn more about the Gift of Life Marrow Registry, visit www.giftoflife.org.

Dendreon

Dendreon Corporation (Nasdaq: DNDN) is a Seattle-based biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Through innovative science and technology, we are striving to develop and commercialize products that address unmet medical need, improve surv...

HealthReveal

HealthReveal is a healthcare technology company whose mission is to preempt the avoidable consequences of chronic disease. A fundamental component of fulfilling this mission is ensuring patients receive guideline-directed medical therapy. Patients suffering from chronic disease receive guideline-directed medical therapy only about 50% of the time1. The con...

CEL-SCI Corporation CEL-SCI Corporation

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. Its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), is currently being studied in a pivotal Phase 3 clinical trial as a potential neoadjuvant treatment for patients with squamous cell carcinoma of the h...

Tmunity Therapeutics, Inc.

Tmunity Therapeutics is a private biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy to patients with devastating diseases. Integrating broad collaborations with the University of Pennsylvania (UPenn) and the University of Minnesota with the groundbreaking scientific, clini...

Aravive Biologics, Inc.

Aravive Biologics is a privately held, late pre-clinical stage biopharmaceutical company developing novel, highly selective cancer therapies that treat serious malignancies while sparing normal healthy cells. The company’s lead program is focused on the GAS6/AXL pathway, where activation appears to play a critical role in multiple types of cancer mali...

Immunomedics, Inc.

Immunomedics (the “Company”) is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases. Immunomedics’ advanced proprietary technologies allow the Company to create humanized antibodies that can be used either alone in unlabeled ...

Lantern Pharma Inc.

Lantern Pharma is a biotech company aiming to re-invent the cancer drug development process by tailoring promising drug programs to the right cancer patients through biomarker discovery. Lantern leverages advanced genomics and machine learning based artificial intelligence (AI) to identify and significantly reduce the cost and overall risk profile of new t...

Synaptive Medical Inc.

“Inoperable means we don’t know how to take it out,” said Dr. Michael Sughrue, Associate Professor, founding member, and current director of the Comprehensive Brain Tumor Center at OU Medicine. “For years we have been operating on the brain the way it looks, now we can operate on the way it really is.”

Medicortex Finland Oy

Medicortex Finland Oy (http://www.medicortex.fi) is a biotechnology company dedicated to improving the diagnostics and treatment of Traumatic Brain Injury (TBI). Is currently developing biomarker diagnostics that evaluate the extent and severity of TBI. Once the company completes this test its next goal will be to develop an innovative drug to halt the pro...

The Lisa Colagrossi Foundation

The Lisa Colagrossi Foundation (TLCF) is the leader in raising awareness and education to help diagnose and treat brain aneurysms. TLCF's primary focus is to communicate the signs, symptoms and risk factors of brain aneurysms through innovation and collaboration with best in class partners in the U.S. and internationally. In the process, we are shedding...

Susan G. Komen and Manduka

Susan G. Komen is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit outside of the federal government while providing real-time help to those facing the disease. Komen has set a Bold Goal to reduce the current number of breast cancer deaths by 50 percent in the U.S. by 2026. Since its founding...

Faxitron® Bioptics, LLC

Faxitron is the industry leader in cabinet x-ray systems for specimen radiography, research, and NDT applications. For more than 50 years, Faxitron has defined cabinet x-ray by continuing to develop best in class x-ray sensor technology and innovative systems. In recent years, our product portfolio has expanded to include disposable medical equipment to me...

Rgenix, Inc.

Rgenix, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancer progression. Using a miRNA based target discovery platform developed by Rgenix’s founders at The Rockefeller University, the company is pursuing several first-in-class drug candida...

Medicortex

Medicortex Finland Oy (http://www.medicortex.fi) is a biotechnology company dedicated to improving the diagnostics and treatment of Traumatic Brain Injury (TBI). Its current focus is to develop biomarker diagnostics that evaluate the extent and severity of TBI. Once the company completes this test its next goal will be to develop an innovative drug to halt...

Proton International

Proton International was founded in 2013 to develop and operate proton centres with high quality clinical partners. Proton International is a subsidiary of Healthcare Technologies International (HTI). HTI began operations in 1972 and has developed over 250 cancer centres on 4 continents and provides private patient cancer services at St. James Cancer Ce...

World Pancreatic Cancer Coalition

The World Pancreatic Cancer Coalition is an international group of pancreatic cancer patient advocacy groups with a mission to drive transformational change for all those affected by the disease. Through global collaboration, the coalition raises awareness of pancreatic cancer by strengthening the efforts of participating member organizations. Each Novembe...

Eureka Therapeutics, Inc.

Eureka Therapeutics, Inc. is a privately held biotechnology company, headquartered in the San Francisco Bay area, focused on developing first-in-class T cell immunotherapies for hematological malignancies and solid tumors. Its core technology platforms center around the discovery and engineering of fully human antibodies against intracellular targets via t...

Quick Search
Advertisement
 

review and buy Cancer market research data and corporate reports here